As of May 27
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Skystar Bio-Pharmaceutical Co have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +1,462.50% increase from the last price of 0.16.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.